SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-072389
Filing Date
2018-12-11
Accepted
2018-12-11 17:02:43
Documents
101
Period of Report
2018-12-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-41116_18k.htm 8-K 27112
2 EX-23.1 a18-41116_1ex23d1.htm EX-23.1 2671
3 EX-99.1 a18-41116_1ex99d1.htm EX-99.1 1203555
  Complete submission text file 0001104659-18-072389.txt   10471951

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT neos-20171231.xml EX-101.INS 2566370
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT neos-20171231.xsd EX-101.SCH 92843
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT neos-20171231_cal.xml EX-101.CAL 83092
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT neos-20171231_def.xml EX-101.DEF 424557
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT neos-20171231_lab.xml EX-101.LAB 886999
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT neos-20171231_pre.xml EX-101.PRE 712490
Mailing Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050
Business Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050 972.408.1360
Neos Therapeutics, Inc. (Filer) CIK: 0001467652 (see all company filings)

IRS No.: 270395455 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37508 | Film No.: 181229370
SIC: 2834 Pharmaceutical Preparations